CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-26 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −4,000 | 18,343 | ||
| 2019-08-15 | KHOSLA CHAITAN PHD Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-08-06 | Liu David Y Chief Scientific Officer | Sale | −3,395 | $8.85 | $30K | 49,802 |
| 2019-08-06 | PATEL DINESH V PH D President and CEO | Sale | −10,792 | $8.85 | $96K | 374,792 |
| 2019-06-07 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-07 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-07 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-07 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-07 | KHOSLA CHAITAN PHD Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-06-07 | Giraudo Bryan Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2019-05-31 | Kalkofen Donald A. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-05-15 | Saks Samuel R Chief Medical Officer | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2019-04-01 | SELICK HAROLD E Director | Option exercise | +3,310 | $1.31 | $4K | 3,310 |
| 2019-04-01 | SELICK HAROLD E Director | Option exercise · Stock Option (right to buy) | −3,310 | 0 | ||
| 2019-03-01 | Liu David Y Chief Scientific Officer | Sale | −810 | $8.03 | $7K | 51,197 |
| 2019-03-01 | PATEL DINESH V PH D President and CEO | Sale | −2,183 | $8.03 | $18K | 383,831 |
| 2019-03-01 | Shames Richard S. Chief Medical Officer | Sale | −657 | $8.03 | $5K | 32,021 |
| 2019-02-28 | Liu David Y Chief Scientific Officer | Grant or award | +15,000 | 52,007 | ||
| 2019-02-28 | Liu David Y Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2019-02-28 | PATEL DINESH V PH D President and CEO | Grant or award | +28,750 | 386,014 |
Page 21 of 29 · 580 trades